Getinge Group has recently performed a strategic review to clarify its long-term strategy for ensuring sustainable and profitable growth. The company will focus on two business areas, Acute Care Therapies and Surgical Workflows.
The Acute Care Therapies offering includes solutions for cardiac, pulmonary and vascular therapies and a broad selection of products and therapies for intensive care. Surgical Workflows develops products and solutions for infection control, equipment for surgical workplaces and advanced IT systems for hospitals.
Based on this long-term strategic direction, the Board of Directors has tasked the management of Getinge Group to prepare for a distribution and listing of Patient & Post-Acute Care, formerly Extended Care, in accordance with Lex ASEA. The proposal is subject to a decision by the shareholders at an Extraordinary General Meeting (EGM) during the fall 2017. Should the EGM approve the Board’s proposal, the aim is to complete the listing not later than during the first quarter of 2018.
“The future listing of Patient & Post-Acute Care will increase the ability of both companies to realize their strategies and to best continue to enhance customer benefits and shareholder value,” says Joacim Lindoff, Acting President & CEO of Getinge Group.
Patient & Post-Acute Care’s offering encompasses products and solutions for safe patient handling, prevention of venous thromboembolisms, medical beds, hygiene systems and early mobility, among others.
Following a split, both companies will have a more concentrated focus, with more opportunities to continue to develop products and solutions to meet customer needs and thereby help solve healthcare challenges.